NCT01332279 2023-04-04Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation TherapyFox Chase Cancer CenterPhase 1 Withdrawn